From periodontitis to neurodegeneration: Can probiotics modulate the <i>P. gingivalis</i> –amyloid pathway in Alzheimer's disease?

and AD, suggesting that probiotics may be used as neuroprotective agents. Taken together, current preclinical signals are consistent with the potential of probiotics as feasible adjuncts, pending confirmatory trials with standardized formulations.